MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Sucampo Pharmaceuticals Company Profile (NASDAQ:SCMP)

Consensus Ratings for Sucampo Pharmaceuticals (NASDAQ:SCMP) (?)
Ratings Breakdown: 2 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $21.88 (104.25% upside)

Analysts' Ratings History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
Show:
DateFirmActionRatingPrice TargetActions
5/5/2016WallachBeth CapitalUpgradeHold -> Buy$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016MizuhoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/4/2016GuggenheimReiterated RatingBuy$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2016Maxim GroupReiterated RatingBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2016Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016Leerink SwannReiterated RatingMarket Perform$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016Jefferies GroupLower Price TargetHold$19.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2015HC WainwrightLower Price Target$36.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015Cantor FitzgeraldDowngradeBuy -> Hold$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Credit SuisseDowngradeNeutral -> Underperform$10.00 -> $13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/27/2014 forward)
Earnings History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
5/4/2016Q116$0.19$0.21$44.11 million$47.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q415$0.19$0.43$42.72 million$55.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315$0.18$0.16$36.18 million$33.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215$0.15$0.21$31.90 million$34.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q114$0.14$0.14$30.19 million$29.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2015Q413$0.17$0.21$37.23 million$37.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q313$0.04$0.03$26.11 million$31.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q213$0.03$0.04$24.06 million$24.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014Q113$0.04$0.02$24.19 million$22.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2014Q4($0.04)$0.06$22.75 million$24.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/13/2013Q4 2012$0.12$0.32$32.21 million$34.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Sucampo Pharmaceuticals (NASDAQ:SCMP)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$0.19$0.26$0.21
Q2 20165$0.20$0.29$0.25
Q3 20164$0.26$0.32$0.29
Q4 20164$0.35$0.38$0.36
(Data provided by Zacks Investment Research)
Dividend History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Sucampo Pharmaceuticals (NASDAQ:SCMP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
8/28/2015Daniel P. GetmanDirectorSell30,000$28.14$844,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/20/2015Thomas J KnappInsiderSell64,528$23.43$1,511,891.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2015William AshtonDirectorSell55,762$17.55$978,623.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2015Anthony C CelesteDirectorSell65,966$17.34$1,143,850.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2014Cary J ClaiborneCFOSell50,000$12.91$645,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Cary J ClaiborneCFOSell7,100$12.89$91,519.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Sachiko KunoMajor ShareholderSell181,727$6.28$1,141,245.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014Ryuji UenoMajor ShareholderSell140,873$6.02$848,055.46View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/31/2014S&R Technology Holdings, LlcMajor ShareholderSell100$6.25$625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2014S&R Technology Holdings, LlcMajor ShareholderSell300$6.25$1,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2014Ryuji UenoMajor ShareholderSell16,155$6.26$101,130.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2014Ryuji UenoMajor ShareholderSell5,845$6.29$36,765.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2014S&R Technology Holdings, LlcMajor ShareholderSell2,500$6.25$15,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/21/2014S&R Technology Holdings, LlcMajor ShareholderSell100$6.25$625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/18/2014S&R Technology Holdings, LlcMajor ShareholderSell15,000$6.27$94,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2014S&R Technology Holdings, Llcmajor shareholderSell113,600$6.65$755,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/25/2014Sachiko Kunomajor shareholderSell118,700$6.69$794,103.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014Gayle DolecekDirectorSell1,200$8.03$9,636.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2014Cary ClaiborneCFOSell2,500$9.00$22,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/17/2014Ryuji UenoCEOSell360,000$10.36$3,729,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2014Cary ClaiborneCFOSell2,500$9.00$22,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/16/2013Sachiko KunoMajor ShareholderSell360,000$6.35$2,286,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013Ryuji UenoCEOSell38,462$5.69$218,848.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Ryuji UenoCEOSell38,462$5.59$215,002.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Ryuji UenoCEOSell38,462$6.04$232,310.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/6/2013Sachiko Kunomajor shareholderSell38,462$6.21$238,849.02View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/24/2013Ryuji UenoCEOSell38,462$6.52$250,772.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/9/2013S&R Technology Holdings, LlcMajor ShareholderSell38,462$6.48$249,233.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2013S&R Technology Holdings, LlcMajor ShareholderSell38,462$6.61$254,233.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2013Sachiko KunoMajor ShareholderSell38,462$7.29$280,387.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Ryuji UenoCEOSell38,462$8.79$338,080.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2013Cary J ClaiborneCFOSell4,640$9.52$44,172.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2013Stanley G MieleSVPSell6,400$9.60$61,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013Stanley G MieleSVPSell48,600$9.67$469,962.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2013Timothy I MaudlinDirectorBuy32,870$9.82$322,783.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Sachiko KunoMajor ShareholderSell38,462$9.27$356,542.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2013S&R Technology Holdings, LlcMajor ShareholderSell38,462$5.22$200,771.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/26/2012S&R Technology Holdings, LlcMajor ShareholderSell20,262$5.01$101,512.62View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2012Sachiko KunoMajor ShareholderSell12,205$5.00$61,025.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2012Sachiko KunoMajor ShareholderSell11,962$5.00$59,810.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2012Sachiko KunoMajor ShareholderSell37,595$5.06$190,230.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Sucampo Pharmaceuticals (NASDAQ:SCMP)
DateHeadline
06/27/16 10:27 AMStrong Sell Calls Recommendations For Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) At 0 - Investor Newswire
06/27/16 10:27 AMSucampo Pharmaceuticals, Inc. (SCMP) Broker Price Targets For The Coming Week - Fiscal Standard
06/25/16 10:01 AMBrokers Issue Average Price Target Of 19.38 On Sucampo Pharmaceuticals, Inc. (SCMP) - Fiscal Standard
06/23/16 08:55 AMSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Yearly Sales Projections At $371.307 - Investor Newswire
06/20/16 05:58 PMStrong Buy Calls Count For Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) At 5 - Investor Newswire
06/20/16 05:58 PMThis Weeks Broker Views For Sucampo Pharmaceuticals, Inc. (SCMP) - Fiscal Standard
06/20/16 02:47 PMSucampo Pharmaceuticals, Inc. – Value Analysis (NASDAQ:SCMP) : June 20, 2016 -
06/15/16 06:13 PMSucampo Pharmaceuticals Inc. (SCMP) Drops 7.44% on June 13 - Equities.com
06/15/16 10:49 AMSucampo Pharmaceuticals Inc. (SCMP) Drops 7.44% on June 13
06/14/16 07:48 AMSucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SCMP-US : June 14, 2016 -
06/12/16 06:17 PMTrend Of Rating Given To Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Investor Newswire
06/08/16 06:48 PMSUCAMPO PHARMACEUTICALS INC. (NASDAQ:SCMP) Financial Condition Compared to S&P 500 - CML News
06/08/16 03:20 PMSUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/07/16 09:04 AMUpcoming Earnings Report: Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - iStreetWire
06/05/16 08:58 AMSucampo Pharmaceuticals' (SCMP) “Buy” Rating Reaffirmed at Mizuho - Let Me Know About This
06/04/16 09:17 AMAnalysts Observing Stocks: Masimo Corporation (NASDAQ:MASI) , Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Street Updates
06/02/16 09:24 AMStock Review and Earnings Check on Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - HNN - Stock Review and Earnings Check on Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP)HNNCompany earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) to report quarterly EPS of $0.22. The company's next earnings report is expected to be ...and more »
06/01/16 09:14 AMSucampo Pharmaceuticals Inc. (SCMP) Jumps 5.7% on May 30 - Equities.com - Sucampo Pharmaceuticals Inc. (SCMP) Jumps 5.7% on May 30Equities.comSucampo Pharmaceuticals Inc. (SCMP) was among the biggest gainers on the Russell 2000 for Monday May 30 as the stock popped 5.7% to $12.42, representing a gain of $0.67 per share. Some 491,236 shares traded hands on 3,463 trades, compared with ...Recently Changed Price Targets On Sucampo Pharmaceuticals, Inc. (SCMP)Risers & FallersSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP)'s Company Shares Increased 15.21% After High VolatilityThe PostWeak On High Volume: Sucampo Pharmaceuticals (SCMP)TheStreet.comEIN News (press release)all 5 news articles »
05/31/16 06:38 PMShare Rating Focus on Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - HNN - Share Rating Focus on Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP)HNNPresently, Wall Street analysts have given a consensus stock rating of 1.57 on shares of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP). Covering analysts will typically provide Buy, Sell, or Hold recommendations based on extensive research.and more »
05/31/16 05:45 AMSucampo Pharmaceuticals Announces Webcast of Its Presentation at the Jefferies 2016 Healthcare Conference - [GlobeNewswire] - ROCKVILLE, Md., May 31, 2016-- Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the Jefferies 2016 Healthcare Conference ...
05/30/16 10:44 PMSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Quarterly EBIT At $-0.503 Millions - Investor Newswire - Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Quarterly EBIT At $-0.503 MillionsInvestor NewswireSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) costs of goods sold was $36.731 millions for the year ended 2016-03-31. This figure was $36.731 for the quarter ended 2016-03-31. Cost of goods sold is recorded by firm on the income statement. It is called ...and more »
05/29/16 11:33 AMSucampo Pharmaceuticals Inc. (SCMP) Jumps 5.7% on May 27 - Equities.com - Sucampo Pharmaceuticals Inc. (SCMP) Jumps 5.7% on May 27Equities.comSucampo Pharmaceuticals Inc. (SCMP) was among the biggest gainers on the Russell 2000 for Friday May 27 as the stock popped 5.7% to $12.42, representing a gain of $0.67 per share. Some 490,473 shares traded hands on 3,460 trades, compared with ...What Will Happen to Sucampo Pharmaceuticals, Inc. Next? The Stock Just Increased A LotFranklin Independentall 4 news articles »
05/29/16 11:33 AMSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Impact Score At 0 - Investor Newswire - Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Impact Score At 0Investor NewswireAlpha One explored various online articles released on Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), and it set a daily sentiment score of 0.285 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring ...Sucampo Pharmaceuticals, Inc. (SCMP) - Broker UpdateRisers & FallersIs it Time to Cash in Profits on Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP)Franklin Independentall 5 news articles »
05/28/16 10:46 AMSucampo Pharmaceuticals Inc. (SCMP) Jumps 5.7% on May 27 - Sucampo Pharmaceuticals Inc. (SCMP) was among the biggest gainers on the Russell 2000 for Friday May 27 as the stock popped 5.7% to $12.42, representing a gain of $0.67 per share. Some 490,473 shares traded hands on 3,460 trades, compared with an average ...
05/27/16 11:51 AMEarnings Review and Stock Rundown for Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) - Wall Street Hints and News - Earnings Review and Stock Rundown for Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP)Wall Street Hints and NewsInvestors and analysts will be paying close attention when the company posts earnings results. Earnings numbers can provide insight into a company's overall profitability. Covering equity analysts are expecting Sucampo Pharmaceuticals, Inc.and more »
05/27/16 11:51 AMSucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Closes At $11.79 - Investor Newswire - Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Closes At $11.79Investor NewswireYesterday, the stock of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) closed at $11.79 after opening at $11.88 and registering high of $11.91 and low of $11.66. The last price is $-17.90 off 1-year high of $29.67 and $2.18 away from low of $9.59 during ...How Analysts Rated Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) Last Week?Wall Street Hints and Newsall 3 news articles »
05/26/16 08:20 AM3 Small-Cap Value Stocks to Power Your Portfolio -
05/18/16 09:50 PMETF’s with exposure to Sucampo Pharmaceuticals, Inc. : May 19, 2016 -
05/17/16 03:00 PMSucampo Pharmaceuticals, Inc. :SCMP-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/17/16 07:25 AMSucampo Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SCMP-US : May 17, 2016 -
05/17/16 05:45 AMSucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2016 UBS Global Healthcare Conference - [GlobeNewswire] - ROCKVILLE, Md., May 17, 2016-- Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the 2016 UBS Global Healthcare Conference ...
05/05/16 08:14 AMSucampo Pharma upgraded by WallachBeth -
05/05/16 05:07 AMSUCAMPO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report -
05/04/16 02:45 PMEdited Transcript of SCMP earnings conference call or presentation 4-May-16 12:30pm GMT -
05/04/16 06:07 AMQ1 2016 Sucampo Pharmaceuticals Inc Earnings Release - Before Market Open -
05/04/16 06:00 AMSucampo Reports Strong Results for First Quarter of 2016 - [at noodls] - Sucampo Reports Strong Results for First Quarter of 2016
05/04/16 05:38 AMSucampo reports 1Q loss -
05/03/16 06:18 AMSucampo Pharmaceuticals Announces Webcast Of Its Presentation At The Bank Of America Merrill Lynch 2016 Healthcare Conference - ROCKVILLE, Md., May 03, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the Bank of America Merrill Lynch 2016 Healthcare ...
03/29/16 04:29 PMETF’s with exposure to Sucampo Pharmaceuticals, Inc. : March 29, 2016 -
03/22/16 12:04 PMSUCAMPO PHARMACEUTICALS, INC. Financials -
03/14/16 03:07 PMETF’s with exposure to Sucampo Pharmaceuticals, Inc. : March 14, 2016 -
03/14/16 11:26 AMSucampo Pharmaceuticals, Inc. :SCMP-US: Earnings Analysis: Q4, 2015 By the Numbers -
03/11/16 05:05 AMSUCAMPO PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report -
03/09/16 02:43 PMSucampo (SCMP) Stock Plunges Despite Strong Q4 Results -
03/09/16 05:45 AMSucampo Pharmaceuticals Announces Webcast of Its Presentation at the 28th Annual ROTH Conference - [GlobeNewswire] - ROCKVILLE, Md., March 09, 2016-- Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, today announced that it will webcast its corporate presentation at the 28 th Annual ROTH Conference on ...
03/08/16 02:17 PMEdited Transcript of SCMP earnings conference call or presentation 8-Mar-16 1:30pm GMT -
03/08/16 07:30 AMSucampo Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today -
03/08/16 06:07 AMQ4 2015 Sucampo Pharmaceuticals Inc Earnings Release - Before Market Open -
03/08/16 05:57 AMSucampo tops Street 4Q forecasts -
03/08/16 05:36 AMSUCAMPO PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclo -
About Sucampo Pharmaceuticals

Sucampo Pharmaceuticals logoSucampo Pharmaceuticals, Inc. is a global biopharmaceutical company. The Company focuses on research and development of drugs to treat gastrointestinal, ophthalmic, and oncology-based inflammatory disorders. It generates revenue from product royalties, development milestone payments, product sales and clinical development activities. Its operations are conducted through Sucampo AG (SAG), based in Zug, Switzerland, through which the Company conducts certain worldwide and European operations; Sucampo Pharma, LLC, based in Tokyo and Osaka, Japan, through which the Company conducts its Asian operations; Sucampo Pharma Americas LLC, based in Bethesda, through which the Company conducts operations in North and South America, and Sucampo Pharma Europe, Ltd., based in Oxford, United Kingdom. The Company's geographic segments are Asia, the Americas and Europe.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: SCMP
  • CUSIP: 86490910
Key Metrics:
  • Previous Close: $10.71
  • 50 Day Moving Average: $11.31
  • 200 Day Moving Average: $12.57
  • P/E Ratio: 20.83
  • P/E Growth: 0.76
  • Market Cap: $448.47M
  • Current Quarter EPS Consensus Estimate: $1.02 EPS
Additional Links:
Sucampo Pharmaceuticals (NASDAQ:SCMP) Chart for Monday, June, 27, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha